Bright Minds Biosciences sets 2026 AGM details

Bright Minds Biosciences Inc. has filed details for its upcoming Annual General Meeting of security holders.

Rhea-AI Filing Summary

Bright Minds Biosciences Inc. has filed details for its upcoming Annual General Meeting of security holders. The record date for notice, voting, and beneficial ownership determination is set for February 10, 2026, meaning holders of common shares on that date will be entitled to participate.

The Annual General Meeting is scheduled for March 31, 2026 in Vancouver. The company will use notice-and-access for both registered and beneficial holders, and it will not send proxy materials directly to NOBOs or pay for delivery to OBOs, indicating that intermediaries will handle most material distribution.

Key Figures

Record Date: February 10, 2026 Meeting Date: March 31, 2026 Meeting Location: Vancouver +2 more

5 metrics

Record Date February 10, 2026 Record date for notice, voting and beneficial ownership determination

Meeting Date March 31, 2026 Annual General Meeting of security holders

Meeting Location Vancouver Location of the 2026 Annual General Meeting

Notice-and-Access for Beneficial Holders Yes NAA requirements for beneficial holders

Notice-and-Access for Registered Holders Yes NAA requirements for registered holders

Key Terms

Record Date for Notice of Meeting, Beneficial Ownership Determination Date, Notice and Access (NAA) Requirements, NOBO, +1 more

5 terms

Record Date for Notice of Meeting financial

"Record Date for Notice of Meeting | February 10, 2026"

Beneficial Ownership Determination Date financial

"Beneficial Ownership Determination Date | February 10, 2026"

Notice and Access (NAA) Requirements regulatory

"Notice and Access (NAA) Requirements: | NAA for Beneficial Holders | Yes"

NOBO financial

"Issuer sending proxy related materials directly to NOBO: | No"

OBO financial

"Issuer paying for delivery to OBO: | No"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Bright Minds Biosciences (DRUG) 2026 Annual General Meeting?

Bright Minds Biosciences’ Annual General Meeting is scheduled for March 31, 2026 in Vancouver. This is when security holders can formally consider corporate matters and vote on items presented in the meeting materials distributed in advance.

What is the record date for Bright Minds Biosciences (DRUG) 2026 AGM?

The record date for notice and voting at Bright Minds Biosciences’ 2026 AGM is February 10, 2026. Shareholders holding common shares on that date will be entitled to receive meeting materials and exercise their voting rights at the AGM.

Where will Bright Minds Biosciences (DRUG) hold its 2026 AGM?

The 2026 Annual General Meeting of Bright Minds Biosciences will be held in Vancouver. The filing identifies Vancouver as the meeting location, with additional logistical details typically provided in the formal notice of meeting and proxy materials.

How will Bright Minds Biosciences (DRUG) deliver proxy materials for the 2026 AGM?

Bright Minds Biosciences will use notice-and-access for both beneficial and registered holders for the 2026 AGM. The issuer will not send materials directly to NOBOs or pay delivery costs for OBOs, so intermediaries will coordinate material distribution.

What is the beneficial ownership determination date for Bright Minds Biosciences (DRUG)?

The beneficial ownership determination date is February 10, 2026, the same as the record date. This date is used to determine which security holders are considered beneficial owners for voting and meeting-related purposes at the 2026 Annual General Meeting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 11:38 AM Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 2026

Commission File No. 001-40997

BRIGHT MINDS BIOSCIENCES INC.
(Translation of registrant's name into English)

400 N Aberdeen St Suite 900
Chicago, IL 60642
(U.S. Corporate headquarters) 1122 Mainland St #228
Vancouver, BC V6B 5L1
(Canadian Corporate headquarters)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F  [  ]  Form 40-F [ X ]

SUBMITTED HEREWITH

Exhibits
99.1	Notice of Annual General Meeting and Record Date

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BRIGHT MINDS BIOSCIENCES INC.

/s/ Ryan Cheung

Ryan Cheung

Chief Financial Officer

Date: June 2, 2026

Date: January 20, 2026

To: All Canadian Securities Regulatory Authorities

Subject: BRIGHT MINDS BIOSCIENCES INC.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type :	Annual General Meeting
Record Date for Notice of Meeting :	February 10, 2026
Record Date for Voting (if applicable) :	February 10, 2026
Beneficial Ownership Determination Date :	February 10, 2026
Meeting Date :	March 31, 2026
Meeting Location (if available) :	Vancouver, BC
Issuer sending proxy related materials directly to NOBO:	No
Issuer paying for delivery to OBO:	No
Notice and Access (NAA) Requirements:
NAA for Beneficial Holders	Yes
Beneficial Holders Stratification Criteria:	Not Applicable
NAA for Registered Holders	Yes
Registered Holders Stratification Criteria:	Not Applicable

Voting Security Details:
Description	CUSIP Number	ISIN
COMMON SHARES	10919W405	CA10919W4056

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 5.9 KB